tiprankstipranks
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
Hong Kong Market
Want to see HK:1858 full AI Analyst Report?

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has a market cap or net worth of HK$5.57B. The enterprise value is HK$808.40.
Market CapHK$5.57B
Enterprise ValueHK$808.40

Share Statistics

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 95,140,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding95,140,500
Owned by Insiders
Owned by Institutions

Financial Efficiency

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.85%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.85%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee970.10K
Profits Per Employee246.28K
Employee Count1,078
Asset Turnover0.29
Inventory Turnover0.73

Valuation Ratios

The current PE Ratio of Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H is 19.7. Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s PEG ratio is 0.16.
PE Ratio19.7
PS Ratio4.89
PB Ratio1.71
Price to Fair Value1.71
Price to FCF14.53
Price to Operating Cash Flow17.98
PEG Ratio0.16

Income Statement

In the last 12 months, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H had revenue of 1.05B and earned 272.54M in profits. Earnings per share was 0.71.
Revenue1.05B
Gross Profit653.40M
Operating Income302.25M
Pretax Income301.71M
Net Income272.54M
EBITDA309.43M
Earnings Per Share (EPS)0.71

Cash Flow

In the last 12 months, operating cash flow was 305.75M and capital expenditures -56.79M, giving a free cash flow of 248.96M billion.
Operating Cash Flow305.75M
Free Cash Flow248.96M
Free Cash Flow per Share2.62

Dividends & Yields

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pays an annual dividend of HK$0.172, resulting in a dividend yield of 4.85%
Dividend Per ShareHK$0.172
Dividend Yield4.85%
Payout Ratio56.24%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.25
52-Week Price Change-51.38%
50-Day Moving Average8.88
200-Day Moving Average12.00
Relative Strength Index (RSI)39.50
Average Volume (3m)684.73K

Important Dates

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H upcoming earnings date is Nov 4, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date

Financial Position

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H as a current ratio of 5.20, with Debt / Equity ratio of 0.10%
Current Ratio5.20
Quick Ratio4.28
Debt to Market Cap0.00
Net Debt to EBITDA-4.54
Interest Coverage Ratio1.50K

Taxes

In the past 12 months, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has paid 29.09M in taxes.
Income Tax29.09M
Effective Tax Rate0.10

Enterprise Valuation

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H EV to EBITDA ratio is 11.99, with an EV/FCF ratio of 10.54.
EV to Sales3.55
EV to EBITDA11.99
EV to Free Cash Flow10.54
EV to Operating Cash Flow9.06

Balance Sheet

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has HK$2.13B in cash and marketable securities with HK$3.06M in debt, giving a net cash position of HK$2.12B billion.
Cash & Marketable SecuritiesHK$2.13B
Total DebtHK$3.06M
Net CashHK$2.12B
Net Cash Per ShareHK$22.31
Tangible Book Value Per ShareHK$7.70

Margins

Gross margin is 67.11%, with operating margin of 28.90%, and net profit margin of 26.06%.
Gross Margin67.11%
Operating Margin28.90%
Pretax Margin28.85%
Net Profit Margin26.06%
EBITDA Margin29.59%
EBIT Margin25.84%

Analyst Forecast

The average price target for Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast10.27%
EPS Growth Forecast79.65%

Scores

Smart Score3
AI Score